SLCO1B3 and cancer: As differential toxicity of natural microcystin variants on cell lines expressing either OATP1B1 or OATP1B3 has been observed [78], [80], these findings raised the question whether microcystins might be suitable as leads for drug substances against these cancer types, and if there are microcystins among the more than 90 known variants that are selectively transported by OATP1B3 relative to OATP1B1.